How Long Does Semaglutide Take to Kick In?

Step 1: the first four weeks — settling in, not speeding up

When semaglutide enters the body it binds to GLP-1 receptors in the gut and brain, slowing gastric emptying and signalling fullness more quickly. That process starts with the very first injection. What you are unlikely to notice in week one is dramatic hunger reduction. The Wegovy titration schedule begins at 0.25 mg — a dose chosen to let your digestive system adjust, not to produce maximum appetite suppression straight away. The body needs a few weeks to respond fully to the circulating levels of the medicine.

Most people report the first real shift in appetite somewhere between weeks two and four, and if you want a detailed breakdown of how quickly semaglutide kicks in across those early weeks, that page walks through what to expect at each stage. Some people feel it earlier; others not until the second or third month. A practical habit worth building: photograph your normal dinner plate at the start of treatment, then look back at it four weeks in. The change in portion size is often the clearest early signal that semaglutide is doing its job.

Side effects in this phase are common and are a sign the medicine is active, nausea, queasiness and loose stools are reported by many people starting GLP-1 treatment. They typically settle within a week or two as the body adapts. Our FAQs cover what to expect in more detail.

Step 2: weeks four to sixteen, dose increases and measurable weight loss

Semaglutide is titrated upward roughly every four weeks: from 0.25 mg to 0.5 mg, then 1 mg, 1.7 mg, and finally 2.4 mg. Each increase tends to bring a renewed appetite response, so if progress plateaus briefly before the next step, that is normal. The dose increases are directed by your prescriber and are not something to adjust yourself.

Weight loss that shows clearly on the scales generally appears somewhere in this window. Four to eight weeks is a reasonable expectation for the first measurable drop. By week sixteen, those on the higher doses in clinical trials were already recording significant reductions. The full detail on individual variability is worth reading if your timeline feels slower than expected, genetics, insulin sensitivity and starting BMI all play a part.

The NHS medicines page on semaglutide explains what to do if you miss a dose during titration. Timing matters more during these early escalation weeks than at maintenance, so keep your prescriber informed if anything disrupts your schedule.

Step 3: months four to eighteen, steady progress toward the full effect

The STEP 1 trial, involving over 1,900 adults without diabetes, tracked participants for 68 weeks. The average body-weight reduction at 2.4 mg maintenance was around 15%, but weight loss continued accumulating well past the six-month mark. In practice that means expecting meaningful progress throughout the first year rather than a rapid result followed by a plateau.

Curious about how semaglutide's pace compares with tirzepatide? The treatment overview covers both options side by side, including the SURMOUNT-5 head-to-head evidence. For questions specific to Wegovy's published results, the Wegovy timeline page goes deeper on what the trial data shows at each time point.

Lifestyle factors compound the medicine's effect. Protein intake, hydration and some form of resistance activity all help preserve lean mass as weight comes down. Your prescriber can point you toward appropriate resources; broad diet targets are beyond what any content page should prescribe for an individual.

When to raise concerns with your prescriber

If you've been on the maintenance dose for three or more months and have seen less than 5% weight loss, that is worth raising at your next clinical review. NICE guidance on semaglutide (TA875) notes that continuing beyond six months without meaningful response should be reconsidered. This is a clinical decision, made with your prescriber, not a reason to increase your dose independently.

Some people find the question of pace generates more anxiety than the weight itself. It's worth knowing that slow starters can catch up as the dose reaches maintenance, and that early appetite changes are a more reliable early signal than the scales alone. If you are specifically using Wegovy and want to understand what the evidence says about timing, our page on how long for Wegovy to kick in covers the clinical picture in detail. If you want to discuss your response with a clinician, our support team is available seven days a week.

Semaglutide (dispensed by our GPhC-registered pharmacy as Wegovy) is a prescription-only medicine. Every prescription is reviewed by a GPhC-registered Independent Prescriber before it is issued, and every repeat order receives the same clinical review before dispatch. If you'd like to explore whether treatment is appropriate for you, speaking to our prescribers is the starting point.